<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01138436</url>
  </required_header>
  <id_info>
    <org_study_id>MEBO-VSU-PII-001 v2.0</org_study_id>
    <nct_id>NCT01138436</nct_id>
  </id_info>
  <brief_title>A Clinical Study of the Safety and Efficacy of MEBO Wound Ointment in Subjects With Venous Leg Ulcers</brief_title>
  <official_title>A Phase II, Randomized, Controlled, Two-Center Pilot Study of the Safety and Efficacy of Topically Applied MEBO® Wound Ointment Compared to Standard of Care in Subjects With Venous Leg Ulcers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Skingenix, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Skingenix, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a Phase II, randomized, controlled, two-center pilot study designed to assess the
      safety and efficacy of MEBO in the treatment of 14 subjects with VLUs. Subjects meeting entry
      criteria will be randomly assigned in a 1:1 ratio for up to 8 weeks of treatment with either
      MEBO or SOC (7 subjects per treatment arm).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To assess the safety and efficacy of MEBO in the treatment of 14 subjects with VLUs. Subjects
      meeting entry criteria will be randomly assigned in a 1:1 ratio for up to 8 weeks of
      treatment with either MEBO or SOC (7 subjects per treatment arm).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2010</start_date>
  <completion_date type="Actual">October 2011</completion_date>
  <primary_completion_date type="Actual">October 2011</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of complete healing of the target ulcer within the 8-week treatment period.</measure>
    <time_frame>8 week treatment period</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">5</enrollment>
  <condition>Ulcers</condition>
  <arm_group>
    <arm_group_label>MEBO Wound Ointment (MEBO)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Topical application once a day</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard of Care</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Application of Profore multilayer compression bandage system</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>MEBO Wound Ointment (MEBO)</intervention_name>
    <description>Topical application once a day</description>
    <arm_group_label>MEBO Wound Ointment (MEBO)</arm_group_label>
    <other_name>MEBO</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Standard of Care</intervention_name>
    <description>Application of Profore multilayer compression bandage system</description>
    <arm_group_label>Standard of Care</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Male or female ≥18 years of age.

          2. Able and willing to provide informed consent.

          3. Able and willing to comply with protocol visits and procedures.

          4. A full-thickness VLU that has been open continuously for ≥4 weeks and ≤1 year.

        Exclusion Criteria:

          1. Ulcer of a non-venous hypertensive pathophysiology.

          2. Known or suspected allergy to any of the components of MEBO.

          3. Malignancy on target ulcer limb.

          4. Received another investigational device or drug within 30 days of enrollment.

          5. Non-compliance in the screening or run-in period.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Robert Kirsner, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>University of Miami</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Center for Clinical Research, Inc.</name>
      <address>
        <city>Castro Valley</city>
        <state>California</state>
        <zip>94546</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Miami Miller School of Medicine</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33136</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 4, 2010</study_first_submitted>
  <study_first_submitted_qc>June 4, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 7, 2010</study_first_posted>
  <disposition_first_submitted>July 19, 2013</disposition_first_submitted>
  <disposition_first_submitted_qc>July 19, 2013</disposition_first_submitted_qc>
  <disposition_first_posted type="Estimate">July 23, 2013</disposition_first_posted>
  <last_update_submitted>April 16, 2018</last_update_submitted>
  <last_update_submitted_qc>April 16, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 18, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Venous Leg Ulcers, VLU</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ulcer</mesh_term>
    <mesh_term>Leg Ulcer</mesh_term>
    <mesh_term>Varicose Ulcer</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted, but a results disposition has been submitted           -->
</clinical_study>

